• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ALTRUA 50; IMPLANTABLE PULSE GENERATOR, PACEMAKER (NON-CRT)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ALTRUA 50; IMPLANTABLE PULSE GENERATOR, PACEMAKER (NON-CRT) Back to Search Results
Model Number S501
Device Problem Premature Discharge of Battery (1057)
Patient Problems Ventricular Tachycardia (2132); No Code Available (3191)
Event Date 09/29/2020
Event Type  Injury  
Manufacturer Narrative
The device is expected to be returned for analysis.This report will be updated upon the completion of the investigation.(b)(4).
 
Event Description
It was reported that premature battery depletion was suspected.The previous device interrogation showed one year of battery remaining, and a magnet rate of 90 bpm.The patient was recently admitted to the hospital, and another device interrogation was performed, which showed the battery status was at eol (end of life).The patient is pacemaker dependent, and had several vt (ventricular tachycardia) episodes with no evidence of pauses longer than 3 seconds.The device was explanted and replaced the following day.No additional adverse patient effects were reported.
 
Event Description
It was reported that premature battery depletion was suspected.The previous device interrogation showed one year of battery remaining, and a magnet rate of 90 bpm.The patient was recently admitted to the hospital, and another device interrogation was performed, which showed the battery status was at eol (end of life).The patient is pacemaker dependent, and had several vt (ventricular tachycardia) episodes with no evidence of pauses longer than 3 seconds.The device was explanted and replaced the following day.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, detailed mechanical and electrical testing was performed on the device.The device battery status was end of life (eol).The device functioned normally throughout testing.Laboratory analysis determined that this device experienced normal battery depletion; however, it was reported from the field that the estimated longevity remaining value appeared to decrease more quickly than expected between routine follow-ups.Factors influencing the estimated longevity remaining calculation include pacing rate, amplitude, pulse-width and lead impedance.Any (even slight) changes in these factors will impact the battery consumption calculation and therefore the remaining longevity estimate.Please note that, despite the drop in estimated longevity remaining, the actual battery condition did not change significantly between follow-ups.In summary, it was determined that this device experienced normal battery depletion, but declared eol earlier than previously estimated.Of note, the estimated remaining battery longevity of this pacemaker was designed to be calculated (and trigger corresponding device replacement indicators) based on the pacing capacitor charge time, which progressively increases as the battery depletes.These pacemakers were not designed with an ability to calculate remaining longevity for every possible current drain, which may cause replacement indicators to trigger earlier than what was previously estimated; however, it does not negatively impact the use, operation, safety, or performance of the device patient code 3191 captures the reportable event of surgery.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALTRUA 50
Type of Device
IMPLANTABLE PULSE GENERATOR, PACEMAKER (NON-CRT)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
MDR Report Key10642727
MDR Text Key210218131
Report Number2124215-2020-19881
Device Sequence Number1
Product Code LWP
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 01/16/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/07/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date09/17/2011
Device Model NumberS501
Device Catalogue NumberS501
Device Lot Number572030
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/11/2020
Date Manufacturer Received11/23/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-